Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1965 1
1987 1
1988 8
1989 27
1990 27
1991 30
1992 33
1993 45
1994 25
1995 10
1996 24
1997 16
1998 21
1999 12
2000 20
2001 9
2002 19
2003 22
2004 28
2005 25
2006 30
2007 27
2008 25
2009 30
2010 58
2011 92
2012 135
2013 169
2014 175
2015 179
2016 169
2017 175
2018 123
2019 112
2020 80
2021 56
2022 24
2023 20
2024 13

Search Results

1,800 results

Results by year

Filters applied: . Clear all
Page 1
Designer drugs: mechanism of action and adverse effects.
Luethi D, Liechti ME. Luethi D, et al. Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6. Arch Toxicol. 2020. PMID: 32249347 Free PMC article. Review.
Designer drugs.
Pesce AJ, Krock K. Pesce AJ, et al. Lab Med. 2023 Nov 2;54(6):553-554. doi: 10.1093/labmed/lmad087. Lab Med. 2023. PMID: 37774399 Free PMC article. No abstract available.
New Designer Drugs.
Levine M, Lovecchio F. Levine M, et al. Emerg Med Clin North Am. 2021 Aug;39(3):677-687. doi: 10.1016/j.emc.2021.04.013. Epub 2021 Jun 9. Emerg Med Clin North Am. 2021. PMID: 34215409 Review.
Deconstructing Designer Drugs.
Sellers EM. Sellers EM. Clin Pharmacol Ther. 2017 Feb;101(2):167-169. doi: 10.1002/cpt.462. Epub 2016 Nov 16. Clin Pharmacol Ther. 2017. PMID: 27564430
Designer drugs – still a threat?
Rozenek EB, Wilczyńska K, Górska M, Waszkiewicz N. Rozenek EB, et al. Przegl Epidemiol. 2019;73(3):337-347. doi: 10.32394/pe.73.23. Przegl Epidemiol. 2019. PMID: 31766831 Review.
Designer drugs: a medicinal chemistry perspective (II).
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2021 Apr;1489(1):48-77. doi: 10.1111/nyas.14349. Epub 2020 May 12. Ann N Y Acad Sci. 2021. PMID: 32396701 Review.
Designer drugs - A continuing chemical (R)evolution.
Taffe MA, Olive MF. Taffe MA, et al. Neuropharmacology. 2018 May 15;134(Pt A):1-3. doi: 10.1016/j.neuropharm.2018.03.037. Epub 2018 Mar 29. Neuropharmacology. 2018. PMID: 29605651 No abstract available.
Benzodiazepines and Related Sedatives.
Peng L, Morford KL, Levander XA. Peng L, et al. Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012. Med Clin North Am. 2022. PMID: 34823725 Review.
The Evolving Landscape of Designer Drugs.
Kacinko SL, Papsun DM. Kacinko SL, et al. Methods Mol Biol. 2019;1872:129-135. doi: 10.1007/978-1-4939-8823-5_13. Methods Mol Biol. 2019. PMID: 30350286
1,800 results